Two of these potential target genes, stathmin (STMN1) and the insulin-like growth factor 1 receptor (IGF1R), attracted attention because both have been reported to be the target genes of miR-223 in hepatocellular carcinoma [24] and cervical cancer [25]. The gene discussed is STMN1; the disease is hepatocellular carcinoma.